4th International Definiens Symposium to Feature More Than 20 Expert Presenters

Definiens announced it will host more than 20 distinguished speakers at the 4th International Definiens Symposium, featuring discussions on image and data analysis in digital pathology.

Munich, Germany, March 5, 2013 / B3C newswire / –Definiens, the global leader of image and data analysis solutions for quantitative digital
pathology, today announced it will host more than 20 distinguished speakers at the 4th International Definiens Symposium, featuring discussions on image and data analysis in digital pathology. The symposium will be held at the Joseph B. Martin Conference Center on Harvard Medical School campus in Boston, MA on May 13-15, 2013.

This annual event will bring together global leading experts from pharmaceutical, biotech and diagnostics companies, as well as academic medical centers to share groundbreaking research and insights on digital pathology. Presenters will highlight how Definiens technology is used in practice to accelerate R&D and discovery of new drugs and biomarkers in automated workflows and how it can be used to innovate new diagnostic tests, increase the success rate of development, reduce time to market and manage the diversity of a broad range of image analysis tasks.

“Definiens is committed to helping researchers and clinicians generate new knowledge that supports personalized medicine and better decisions in research, diagnostics and therapy,” said Thomas Heydler, CEO of Definiens. “Advanced image and data analysis is critical to enhancing diagnostics and clinical digital pathology. We’re thrilled to be working with such an esteemed group of presenters to share knowledge that can
lead to improved decision making and better outcomes for patients.”

The symposium will feature plenary talks as well as hands-on workshops to encourage collaboration and the sharing of best practices. Sessions will include:

• Taking Tissue
  Diagnostics into the 21st Century
• Advancing Drug
  Development
• Embracing
  Digital Pathology - The Business Perspective (includes panel discussion)

“The Definiens symposium hasbecome a leading forum for discussions on image and data analysis in digital pathology,” said Dr. Thomas Nifong, VP of Clinical Operations, Metamark Genetics. “It provides an important setting for sharing new academic and clinical research and promoting advancements in the industry.”

What: 4th International Definiens Symposium:
Empowering Digital Pathology

When: May 13-15, 2013

Who Should Attend: Researchers and clinicians in the life
sciences, diagnostic biomarkers and healthcare industries

Where:
Joseph B. Martin conference center, Harvard Medical School Campus, Boston, MA,
USA